John Plater of the Canadian Hemophilia Society expressed bewilderment at the verdict. "If you, on the one hand, have a study that says there's a problem, and on the other hand have a study that says maybe there isn't a problem, any reasonable person takes the product off the market. They didn't. People were infected, and people died," Plater said. "How that could be considered reasonable behavior is beyond us."
Dutch boast world’s first printed bike bridge
21 hours ago